EAU 2023 Kidney Cancer

Viewing 1-9 of 9 articles

EAU 2023: European Urology Oncology Lecture: The Future of Systemic Treatment in Patients with Locally Advanced and Metastatic Renal Cell Carcinoma

EAU 2023: UroCCR Study 120: Development of an Individual Postoperative Prediction Model for Kidney Cancer Recurrence Using Machine Learning

EAU 2023: Patient Experience with Recurrence of Renal Cell Carcinoma

EAU 2023: Refining the Indication for Adjuvant Pembrolizumab in Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence Using a Risk-Adapted Approach: A Contemporary Multicenter Study

EAU 2023: Utility of Adjuvant Immunotherapy in High-Risk Non-Metastatic Renal Cell Carcinoma: A Real-World Experience Using National Cancer Database Analysis

EAU 2023: Artificial Intelligence to Predict Recurrence after Surgical Resection of Non-metastatic Renal Cell Carcinoma: Is It Any Better than Conventional Systems?

EAU 2023: Burning Questions in Oncological Urology: How to Integrate Metastasis-Directed and Systemic Treatment in Patients with Oligometastatic Renal Cell Carcinoma

EAU 2023: Discussant: 89Zr-DFO-Girentuximab for PET/CT Imaging of Clear Cell Renal Cell Carcinoma - Results from Phase 3 ZIRCON Study

EAU 2023: 89Zr-DFO-Girentuximab for PET/CT Imaging of Clear Cell Renal Cell Carcinoma - Results from Phase 3 ZIRCON Study